Veterinary medicine

ElleVet Academy Launches with Classes on Cannabinoid Veterinary Science, Offering Free RACE Approved CE Credits for Veterinary Professionals

Retrieved on: 
Thursday, February 15, 2024
CE, Anxiety, Research, Education, Atopic dermatitis, Dog, Parent, Cannabinoid, Curriculum, Entrepreneurship, Veterinary medicine, Pharmacokinetics, Cat, Patient, CBD, Knowledge, Osteoarthritis, Epilepsy, Science

PORTLAND, Maine, Feb. 15, 2024 /PRNewswire-PRWeb/ -- ElleVet Sciences, the leading authority on cannabinoid veterinary science, proudly announces the launch of ElleVet Academy (ellevetacademy.com), its online learning platform offering free continuing education (CE) credits to veterinary professionals. ElleVet Academy courses aim to empower veterinary professionals with the knowledge and skills needed to confidently incorporate cannabinoid-based products into their practice to support patients with osteoarthritis, epilepsy, atopic dermatitis, and anxiety.

Key Points: 
  • PORTLAND, Maine, Feb. 15, 2024 /PRNewswire-PRWeb/ -- ElleVet Sciences, the leading authority on cannabinoid veterinary science, proudly announces the launch of ElleVet Academy ( ellevetacademy.com ), its online learning platform offering free continuing education (CE) credits to veterinary professionals.
  • "ElleVet Academy represents a pivotal step in advancing veterinary education," said Dr. Joseph J. Wakshlag, Chief Veterinary Medical Officer, ElleVet Sciences.
  • Free Continuing Education Credits: Veterinary professionals can earn RACE-approved CE credits at no cost, making ElleVet Academy the most accessible and comprehensive resource for gaining essential education in cannabinoid veterinary science.
  • Scientific Expertise: ElleVet Academy courses were designed by the same veterinary professionals and researchers who brought cannabinoid veterinary science to the forefront of pet care.

BioElectronics Chairman Updates Investors

Retrieved on: 
Thursday, February 15, 2024
University, Motion, Doctor of Philosophy, OTC, Quality of life, Pain, Dog, Sale, Arthritis, Veterinary medicine, Thumb, Society, Chronic pain, Patient, Knee, Clinical trial, Osteoarthritis, Hand, Stanford University Medical Center, Literature, Twilight anesthesia, UCSD, Research, Audit

FREDERICK, MD, Feb. 15, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today releases an update from its Chairman, Richard Staelin, PhD.

Key Points: 
  • FREDERICK, MD, Feb. 15, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation ( https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today releases an update from its Chairman, Richard Staelin, PhD.
  • The intent of this short update is to provide potential investors and current stockholders as much information as possible on the progress of our Company over these last three months and our future plans.
  • Today, I will focus on the first of these, although I will briefly mention the two other vital components of our mission.
  • Such findings will be new to the literature and should provide important evidence on reducing opioid use and minimizing post-surgical chronic pain.

39.2% of Veterinary Professionals Use AI Tools in Their Practice - Digitail and AAHA Survey

Retrieved on: 
Thursday, February 15, 2024
Shift, AI, Veterinary medicine, AAHA, Radiology, Perception, American Animal Hospital Association, Diagnosis, Artificial intelligence, Software, Medical device

WILMINGTON, Del., Feb. 15, 2024 /PRNewswire/ -- Digitail, an all-in-one practice management software for veterinary hospitals, published a study, "AI in Veterinary Medicine: The Next Paradigm Shift," exploring current awareness, perception, utilization, expectations, and concerns around the adoption of AI in veterinary medicine. Conducted in collaboration with the American Animal Hospital Association (AAHA), the study collected perspectives from 3,968 veterinary professionals. Below are the study highlights.

Key Points: 
  • Conducted in collaboration with the American Animal Hospital Association (AAHA), the study collected perspectives from 3,968 veterinary professionals.
  • 39.2% of respondents reported using AI tools or software in their veterinary setting.
  • 38.7% of veterinary professionals are interested in incorporating AI tools into their practice in the near future, while 15.5% of respondents expressed a clear opposition to AI.
  • Notably, the overwhelming majority of those veterinary professionals who have tapped into AI, are using these tools in their veterinary setting daily or weekly," commented Sebastian Gabor, CEO at Digitail.

Olansky Dermatology & Aesthetics welcomes Dr. Ajdin Kobic to acclaimed roster

Retrieved on: 
Wednesday, February 14, 2024
Mohs surgery, Skin cancer, Psoriasis, Suite, Blepharoplasty, Dermatology, Society, Emory University, Mayo Clinic, Clinical professor, American College, Patient, Family, Plastic surgery, Laser, Aesthetics, American Academy, Veterinary medicine

ATLANTA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Olansky Dermatology & Aesthetics –Georgia’s top-rated dermatology practice– welcomes Dr. Ajdin Kobic, a board-certified dermatologist and fellowship-trained Mohs micrographic and reconstructive surgeon.

Key Points: 
  • ATLANTA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Olansky Dermatology & Aesthetics –Georgia’s top-rated dermatology practice– welcomes Dr. Ajdin Kobic, a board-certified dermatologist and fellowship-trained Mohs micrographic and reconstructive surgeon.
  • With the addition of Dr. Kobic to the practice’s acclaimed team, patients can continue to choose Olansky Dermatology & Aesthetics with confidence.
  • “Patients looking to rejuvenate and revitalize their appearance have an incredible asset in Dr. Kobic,” says Dr. Jodi Ganz, physician partner at Olansky Dermatology & Aesthetics.
  • To schedule an appointment with Dr. Kobic at Olansky Dermatology & Aesthetics, visit OlanskyDermatology.com/Schedule or call: 404-355-5484.

Animal Therapeutics and Diagnostics Global Market Report 2024 - Dermatological Disease Management in Animals to Propel Market Growth

Retrieved on: 
Tuesday, February 13, 2024
Therapy, Pet, Incidence, Disease, Biotechnology, Livestock, Zoonosis, Veterinary medicine, Telehealth, Animal, Growth, Digital, Veterinarian, Health, Landmark, Organization, Medicine

DUBLIN , Feb. 13, 2024 /PRNewswire/ -- The "Animal Therapeutics and Diagnostics Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN , Feb. 13, 2024 /PRNewswire/ -- The "Animal Therapeutics and Diagnostics Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.
  • The global animal therapeutics and diagnostics market is poised for continued expansion, buoyed by a compelling compound annual growth rate and disruptive technological advancements.
  • With digital advancements, telemedicine is becoming an integral part of the animal therapeutics and diagnostics market, promoting access to essential healthcare services for pets.
  • This insightful market research report highlights the robust potential of the animal therapeutics and diagnostics domain as it gears up for significant technological pivots in the post-pandemic era.

According to a New Study, Veterans with PTSD Who Had Service Dogs Showed Healthier Cortisol Levels Compared to Those Without

Retrieved on: 
Tuesday, February 13, 2024
Bangladesh Technical Education Board, K9s for Warriors, Mental health, Hearing, Research, College, NIH, University, Quality of life, Suicide, Dog, Overalls, Veterinary medicine, Learning, Saliva, Dean (education), Organization, PTSD, Veteran, Warrior, Partnership, Pharmaceutical industry

PHOENIX, Feb. 13, 2024 /PRNewswire/ -- New research from The University of Arizona College of Veterinary Medicine looked at the impact service dogs had on the cortisol levels of veterans suffering from PTSD. The study found that those with service dogs had healthier cortisol levels when compared to those without service dogs. The research, led by Dr. Maggie O'Haire, Associate Dean for Research and Professor at the College of Veterinary Medicine, and Dr. Leanne Nieforth, with the help of K9s For Warriors and funding support from the Dogtopia Foundation, the National Institutes of Health (NIH) and Purina, provides further evidence of the positive benefits service dogs offer veterans.

Key Points: 
  • The study found that those with service dogs had healthier cortisol levels when compared to those without service dogs.
  • The study assessed a total of 161 veterans who had PTSD, 88 who had a service dog and 73 who did not.
  • The study concluded that overall, veterans with service dogs had stress hormones more like those in healthy adults without PTSD than veterans without service dogs.
  • The U.S. Department of Veterans Affairs (VA), a key provider for veterans, has been hesitant to allocate funds for service dogs for individuals dealing with PTSD service dogs, citing a lack of clinical evidence substantiating their effectiveness.

Adtalem Global Education Names Scott Liles as the New Medical and Veterinary President

Retrieved on: 
Tuesday, February 13, 2024
Veterinary, Pets, Health Insurance, Other Education, Continuing, General Health, University, Consumer, Health, Education, U.N, Financial services, Doctor of Philosophy, Medicine, Nationwide, Growth, Adtalem Global Education, AUC, Veterinary medicine, MBA, RUSM, Accenture, London Business School, American University, McKinsey & Company, ACAMS, Economics, Texas A&M University, ATGE, Management

Adtalem Global Education Inc. (NYSE: ATGE), a national leader in post-secondary education and the nation’s largest healthcare educator1, has appointed Scott Liles as president, Adtalem medical and veterinary, effective April 1.

Key Points: 
  • Adtalem Global Education Inc. (NYSE: ATGE), a national leader in post-secondary education and the nation’s largest healthcare educator1, has appointed Scott Liles as president, Adtalem medical and veterinary, effective April 1.
  • In his new role, Liles will have principal responsibility for the academic, operational and financial outcomes of the Medical and Veterinary reporting segment.
  • His strong business acumen and expertise in leading global organizations make him a fantastic addition to the Adtalem leadership team,” said Steve Beard, president and CEO, Adtalem Global Education.
  • “It’s an honor to rejoin the Adtalem family and be part of the solution to fulfilling the needs of the healthcare workforce while impacting local and global communities,” said Scott Liles, president, Adtalem medical and veterinary.

ECO Animal Health Appoints Dr. Joachim Hasenmaier as Non-Executive Director

Retrieved on: 
Monday, February 12, 2024
Acquisition, The Elements of Style, Doctor of Philosophy, Boehringer Ingelheim Animal Health, Health, Growth, ECO, Veterinary medicine, MBA, AIM, Vaccine, Boehringer Ingelheim, McKinsey & Company, Animal Health, Mars, Incorporated, Ageing, Management

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces the appointment of Dr. Joachim Hasenmaier as a Non-Executive Director, with immediate effect.

Key Points: 
  • ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces the appointment of Dr. Joachim Hasenmaier as a Non-Executive Director, with immediate effect.
  • Dr. Hasenmaier is a highly experienced commercial leader with more than two decades in the international animal health industry.
  • From 2001 to 2019 he held a variety of senior roles within the animal health division at Boehringer Ingelheim, concluding as member of the Board of Managing Directors responsible for the entire animal health division.
  • Dr. Andrew Jones, Chairman of ECO, commented: “On behalf of the Board, I am delighted to welcome Joachim as a Non-Executive Director to ECO.

Novel lower-cost blood test for cancer screening in dogs validated in large clinical study by PetDx

Retrieved on: 
Friday, February 9, 2024
Carcinoma, SAN, Cancer, American Veterinary Medical Association, Liquid biopsy, Leukemia, Lymphoma, DNA, Risk, Hemangiosarcoma, Journal, Osteosarcoma, Veterinary medicine, Dog, Histiocytic sarcoma, JAVMA, Medical imaging

SAN DIEGO, Feb. 9, 2024 /PRNewswire/ -- PetDx® – The Liquid Biopsy Company for Pets™ published a clinical validation study this week showing that its new OncoK9® Screen test has a high detection rate across seven predefined, clinically relevant cancer types that represent a large proportion of all cancers found in dogs and are often difficult to detect by physical exam alone due to their anatomic location and/or lack of specific clinical signs. These cancer types are often aggressive, requiring prompt intervention, and have typically been associated with improved outcomes when detected and treated early.

Key Points: 
  • By integrating cell-free DNA quantification and next-generation sequencing using a proprietary method, the new test can be performed faster and at lower cost than the company's flagship OncoK9® Dx test, allowing for broader access to blood-based cancer screening in dogs.
  • These cancer types are often aggressive, requiring prompt intervention, and have typically been associated with improved outcomes when detected and treated early.
  • "Previously published research has shown that only around 10% of cancer cases are currently detected in dogs prior to the onset of clinical signs.
  • "The availability of comprehensively validated blood-based cancer detection tools that can be readily incorporated into preventive care protocols opens the door to the development of cancer screening guidelines for early cancer detection in dogs."

SAN FRANCISCO SPCA RECEIVES $200,000 GRANT FROM PETSMART CHARITIES TO IMPROVE ACCESS TO VETERINARY CARE

Retrieved on: 
Thursday, February 8, 2024
SAN, Veterinarian, Family, SF, SPCA, Animal, Accelerator, Pet, PetSmart Charities, Dog, Charitable organization, PetSmart, Veterinary medicine

SAN FRANCISCO, Feb. 8, 2024 /PRNewswire/ -- The San Francisco SPCA (SF SPCA) has been awarded a $200,000 grant to support the organization's Community Veterinary Clinic, which opened in San Francisco's Excelsior District in 2022. The grant funding comes from PetSmart Charities' "Accelerator" program, which is committed to improving access to veterinary care throughout North America.

Key Points: 
  • The grant funding comes from PetSmart Charities' "Accelerator" program, which is committed to improving access to veterinary care throughout North America.
  • "We are honored to receive this generous funding from PetSmart Charities," said SF SPCA Chief Executive Officer, Dr. Jennifer Scarlett.
  • PetSmart Charities' invaluable support will play a critical role in providing access to care for all companion animals and their families."
  • In 2023, PetSmart Charities committed $100 million over the next five years toward improving access to veterinary care.